

Trials of the Week: Nimodipine Landmark Studies
Apr 5, 2024
Salia Farrokh, a clinical pharmacist specialist, discusses landmark studies on nimodipine for aneurysmal subarachnoid hemorrhage in the 1980s. Topics include study methodology evolution, dosing regimens, missed doses, and the relevance of old evidence in current practices.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 4min
Exploring Nimodipine Landmark Studies in Critical Care
03:45 • 1min
Management of Adverse Effects in Aneurysmal Subarachnoid Hemorrhage
05:15 • 16min
Analyzing Landmark Nimodipine Studies from the 1980s
21:26 • 2min
Landmark Study on Nimodipine and Subarachnoid Hemorrhage
23:38 • 19min
Exploring Landmark Studies on the Neurocritical Care Drug Nimodipine
43:02 • 2min